Clinical Trials Browser

Phase 2 × Recruiting × pirarubicin × Clear all

NCT04437160 2020-06-18

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Phase 2 Recruiting

Triple Negative Breast Neoplasms